Status:
UNKNOWN
The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection
Lead Sponsor:
Fooyin University
Conditions:
Bowel Dysfunction
Helicobacter Pylori Infection
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
People nowadays tend to have irregular diet and routine due to the stress at work. This condition may cause intestinal microflora imbalance, and in the long term may lead to constipation, diarrhea, ga...
Eligibility Criteria
Inclusion
- Inclusion Criteria (PART I : For patients with bowel disorders):
- Constipation : Must include 2 or more of the following:
- straining during at least 25% of defecations
- lumpy or hard stools in at least 25% of defecations
- sensation of incomplete evacuation for at least 25% of defecations
- sensation of anorectal obstruction/blockage for at least 25% of defecations
- manual maneuvers to facilitate at least 25% of defecations
- fewer than 3 defecations per week
- Diarrhea :
- the passage of 3 or more loose or liquid stools per day and lasting more than 1 week, or more frequently than is normal for the individual.
- Inclusion Criteria (PART II : For patients with Helicobacter pylori infection):
- Campylobacter-like organism test (CLO test) positive
- Exclusion Criteria (PART I \& II)
- prior upper digestive tract surgery
- a history of cancer
- lactose intolerance
- allergy to penicillin
- prior antibiotics therapy in the last month
- prior probiotics supplement more than once a week in the last three weeks
Exclusion
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04319991
Start Date
November 15 2019
End Date
November 1 2021
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fooyin University Hospital
Pingtung City, Taiwan, 92847